Folate Analog Metabolic Inhibitor [EPC]

278808 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

#	Side effect	Count
0	DRUG INEFFECTIVE	46332
1	RHEUMATOID ARTHRITIS	23474
2	ARTHRALGIA	20850
3	PAIN	18724
4	NAUSEA	15026
5	FATIGUE	14676
6	INJECTION SITE PAIN	12634
7	OFF LABEL USE	12300
8	HEADACHE	12169
9	JOINT SWELLING	11754

See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	HUMAN ANTICHIMERIC ANTIBODY POSITIVE	252	0.8780
1	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE	700	0.8028
2	RED BLOOD CELL SEDIMENTATION RATE ABNORMAL	1101	0.7058
3	RHEUMATOID FACTOR POSITIVE	1010	0.6738
4	C-REACTIVE PROTEIN ABNORMAL	1673	0.6571
5	SYNOVITIS	4618	0.5837
6	PEMPHIGUS	1488	0.5333
7	GRANULOMA SKIN	227	0.5255
8	BODY HEIGHT BELOW NORMAL	291	0.4932
9	RHEUMATOID NODULE	884	0.4879

See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]